Aster Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-230
Closed -$4.17K 1048
2026
Q1
$4.17K Buy
+230
New +$4.95K ﹤0.01% 695
2025
Q3
Sell
-248
Closed -$4.98K 1160
2025
Q2
$4.98K Buy
+248
New +$4.77K ﹤0.01% 864
2025
Q1
Sell
-1,034
Closed -$17.9K 1459
2024
Q4
$17.9K Buy
1,034
+832
+412% +$16K 0.01% 654
2024
Q3
$3.9K Buy
+202
New +$3.72K ﹤0.01% 931

Other funds holding INVA

Aster Capital Management's INVA Position: Q2 2026 in Review

Aster Capital Management sold out of Innoviva (INVA) in Q2 2026, closing a stake of 230 shares — an estimated $4.17K sold.

Aster Capital Management first reported a position in INVA in Q3 2024 and held it in 4 quarters. The position peaked at $17.9K in Q4 2024. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Aster Capital Management reported no remaining Innoviva position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 230 Innoviva shares in Q2 2026, an estimated $4.17K.
  • Aster Capital Management first reported a position in Innoviva in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Innoviva position peaked at $17.9K in Q4 2024.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.